Stay updated on Itolizumab in Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.

Latest updates to the Itolizumab in Lupus Nephritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedNew site revision note added: Revision: v3.3.3. The HHS Vulnerability Disclosure entry and the previous Revision: v3.3.2 reference were removed.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, replacing v3.3.1; no study data or user-facing content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history shows Revision: v3.3.1 in place of Revision: v3.2.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved a site-wide notice about a lapse in government funding and NIH operating status. The banner previously informed users that information might not be up to date and pointed to alternate sources for status updates.SummaryDifference0.7%

- Check65 days agoChange DetectedThe new version updates the study status and related sections for NCT04128579, including Study Design, Outcome Measures, and Eligibility.SummaryDifference0.2%

- Check94 days agoChange DetectedCore content updated to reflect new operating status and funding notice; version bumped from v3.1.0 to v3.2.0, replacing the old version reference.SummaryDifference12%

Stay in the know with updates to Itolizumab in Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.